At ADA 2023, Breakthrough T1D-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
Breakthrough T1D joined thousands at the ADA's Scientific Sessions, where experts presented significant advancements in diabetes research and clinical trials.
ADA’s Scientific Sessions: Takeaways Day 3
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for…
ADA’s Scientific Sessions: Takeaways Day 2
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for…
ADA’s Scientific Sessions: Takeaways Day 1
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for…
Breakthrough T1D Heads to ADA’s 83rd Scientific Sessions Diabetes Conference
From June 23-26, Breakthrough T1D researchers will present new study results at the American Diabetes Association's 83rd Scientific Sessions.
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
Could drugs like Ozempic also benefit people with type 1 diabetes?
Learn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help…
FDA Clears a New Artificial Pancreas System
The FDA cleared the iLet Insulin-Only Bionic Pancreas System for people 6 years of age and older with type 1…
Clinical Trials: The Ultimate Form of T1D Advocacy
Meet two type 1 diabetes (T1D) clinical trial participants who are helping improve lives and getting us closer to cures,…
